{
    "title": "New drug reduces heart attacks, but is that enough?",
    "url": "https://www.dailymail.co.uk/wires/ap/article-4832122/New-drug-reduces-heart-attacks-enough.html",
    "date": "2017-08-29",
    "keywords": [
        "drug",
        "cholesterol",
        "heart",
        "merck",
        "study",
        "market",
        "approval",
        "company",
        "percent",
        "statin",
        "taylor",
        "type",
        "conference",
        "pill",
        "medicine",
        "trenton",
        "soso",
        "quandary",
        "longterm",
        "need",
        "convince",
        "thursday",
        "file",
        "photograph",
        "logo",
        "glass",
        "panel",
        "building",
        "kenilworth",
        "meant",
        "drugmaker",
        "call",
        "photomel",
        "tuesday",
        "barcelona",
        "spain",
        "journal",
        "anacetrapib",
        "kind",
        "result",
        "disease",
        "killer",
        "process",
        "analyst",
        "president",
        "safety",
        "pool",
        "brozak",
        "price",
        "bill",
        "brandname",
        "lipitor",
        "crestor",
        "zocor",
        "month",
        "repatha",
        "praluent",
        "category",
        "cost",
        "year",
        "georgetown",
        "university",
        "cardiologist",
        "dr",
        "j",
        "food",
        "administration",
        "benefit",
        "youll",
        "chance",
        "event",
        "attack",
        "procedure",
        "bypass",
        "surgery",
        "stent",
        "artery",
        "expensive",
        "era",
        "group",
        "dummy",
        "prevent",
        "side",
        "effect",
        "accumulation",
        "tissue",
        "johnson",
        "httpstwittercomlindaj_onpharma"
    ],
    "category": [
        "wires",
        "ap"
    ]
}